These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 16617160)
1. Pivotal Advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. Cormier SA; Taranova AG; Bedient C; Nguyen T; Protheroe C; Pero R; Dimina D; Ochkur SI; O'Neill K; Colbert D; Lombari TR; Constant S; McGarry MP; Lee JJ; Lee NA J Leukoc Biol; 2006 Jun; 79(6):1131-9. PubMed ID: 16617160 [TBL] [Abstract][Full Text] [Related]
2. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. Mould AW; Matthaei KI; Young IG; Foster PS J Clin Invest; 1997 Mar; 99(5):1064-71. PubMed ID: 9062365 [TBL] [Abstract][Full Text] [Related]
3. The effect of IL-5 and eotaxin expression in the lung on eosinophil trafficking and degranulation and the induction of bronchial hyperreactivity. Mould AW; Ramsay AJ; Matthaei KI; Young IG; Rothenberg ME; Foster PS J Immunol; 2000 Feb; 164(4):2142-50. PubMed ID: 10657668 [TBL] [Abstract][Full Text] [Related]
4. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. Shen HH; Ochkur SI; McGarry MP; Crosby JR; Hines EM; Borchers MT; Wang H; Biechelle TL; O'Neill KR; Ansay TL; Colbert DC; Cormier SA; Justice JP; Lee NA; Lee JJ J Immunol; 2003 Mar; 170(6):3296-305. PubMed ID: 12626589 [TBL] [Abstract][Full Text] [Related]
5. Interview with Dr. Nancy A. Lee and Dr. James J. Lee regarding Pivotal Advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. Interview by Helene F. Rosenberg. Lee NA; Lee JJ J Leukoc Biol; 2006 Jun; 79(6):1129-30. PubMed ID: 16751625 [No Abstract] [Full Text] [Related]
6. Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process. Mattes J; Hulett M; Xie W; Hogan S; Rothenberg ME; Foster P; Parish C J Exp Med; 2003 Feb; 197(3):387-93. PubMed ID: 12566422 [TBL] [Abstract][Full Text] [Related]
7. Role of CD4+ T lymphocytes and interleukin-5 in antigen-induced eosinophil recruitment into the site of cutaneous late-phase reaction in mice. Iwamoto I; Tomoe S; Tomioka H; Takatsu K; Yoshida S J Leukoc Biol; 1992 Nov; 52(5):572-8. PubMed ID: 1358993 [TBL] [Abstract][Full Text] [Related]
8. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Rothenberg ME; Ownbey R; Mehlhop PD; Loiselle PM; van de Rijn M; Bonventre JV; Oettgen HC; Leder P; Luster AD Mol Med; 1996 May; 2(3):334-48. PubMed ID: 8784786 [TBL] [Abstract][Full Text] [Related]
9. An essential role for antibody in neutrophil and eosinophil recruitment to the cornea: B cell-deficient (microMT) mice fail to develop Th2-dependent, helminth-mediated keratitis. Hall LR; Lass JH; Diaconu E; Strine ER; Pearlman E J Immunol; 1999 Nov; 163(9):4970-5. PubMed ID: 10528201 [TBL] [Abstract][Full Text] [Related]
10. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils. Pettipher R; Vinall SL; Xue L; Speight G; Townsend ER; Gazi L; Whelan CJ; Armer RE; Payton MA; Hunter MG J Pharmacol Exp Ther; 2012 Feb; 340(2):473-82. PubMed ID: 22106101 [TBL] [Abstract][Full Text] [Related]
11. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection. Dobrzanski MJ; Reome JB; Dutton RW J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679 [TBL] [Abstract][Full Text] [Related]